{"id":4895,"date":"2025-12-10T09:50:50","date_gmt":"2025-12-09T23:50:50","guid":{"rendered":"\/americas\/?p=4895"},"modified":"2025-12-10T09:50:50","modified_gmt":"2025-12-09T23:50:50","slug":"orthocell-strengthens-asian-growth-platform-with-first-commercial-sales-in-hong-kong","status":"publish","type":"post","link":"\/americas\/orthocell-strengthens-asian-growth-platform-with-first-commercial-sales-in-hong-kong\/","title":{"rendered":"Orthocell Strengthens Asian Growth Platform with First Commercial Sales in Hong Kong"},"content":{"rendered":"<p><span data-contrast=\"auto\">Orthocell has announced that it has completed the first commercial sales of Remplir\u2122 in Hong Kong, representing a key milestone in the Company\u2019s Asian growth strategy.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">These initial sales follow the successful introduction of Remplir in Hong Kong, including its first surgical use and strong reception at the Hong Kong Orthopaedic Association (HKOA) 45th Annual Congress.\u00a0 These first sales to MontsMed provide immediate in-market availability and are expected to support multiple downstream sales as surgeons adopt the technology.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Hong Kong represents a strategically important entry point into the Guangdong\u2013Hong Kong\u2013Macao Greater Bay Area (GBA), one of Asia\u2019s most dynamic healthcare regions with a population of approximately 100 million people.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Orthocell\u2019s Chief Scientific Officer, Professor Minghao Zheng, is currently in Hong Kong delivering distributor onboarding and scientific training with the MontsMed team. This program is designed to support MontsMed\u2019s early commercial activities by empowering clinical and sales teams to drive engagement with specialist surgeons.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Orthocell CEO and MD, Paul Anderson said:\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">\u201cFirst Hong Kong sales represent an important commercial milestone for Orthocell and a strong validation of Remplir\u2019s clinical value. We are well positioned to support MontsMed in driving adoption across leading hospitals in Hong Kong and the Greater Bay Area. We are executing our commercialisation strategy with discipline, and today\u2019s achievement marks another step forward in establishing Remplir as a new standard of care in peripheral nerve repair.\u201d<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/cdn-api.markitdigital.com\/apiman-gateway\/ASX\/asx-research\/1.0\/file\/2924-03035542-6A1302562&amp;v=undefined\"><span data-contrast=\"auto\">Read the ASX release<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell has announced that it has completed the first commercial sales of Remplir\u2122 in Hong Kong, representing a key milestone in the Company\u2019s Asian growth strategy.<\/p>\n","protected":false},"author":2,"featured_media":4744,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4895","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"aioseo_notices":[],"_links":{"self":[{"href":"\/americas\/wp-json\/wp\/v2\/posts\/4895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/americas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/americas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/comments?post=4895"}],"version-history":[{"count":1,"href":"\/americas\/wp-json\/wp\/v2\/posts\/4895\/revisions"}],"predecessor-version":[{"id":4896,"href":"\/americas\/wp-json\/wp\/v2\/posts\/4895\/revisions\/4896"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/media\/4744"}],"wp:attachment":[{"href":"\/americas\/wp-json\/wp\/v2\/media?parent=4895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/categories?post=4895"},{"taxonomy":"post_tag","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/tags?post=4895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}